Mechanical signals in aging: mechanisms and therapeutic strategies.
Key claim: Cellular mechanics and mechanotransduction critically regulate senescence initiation and progression, and mechanics-based interventions (stimulation, microenvironment remodeling, targeted mechanotransduction modulation) hold therapeutic potential for aging and regenerative medicine.
Abstract
Cellular senescence is a fundamental driver of aging and age-related diseases. While traditionally attributed to biochemical cues, accumulating evidence identifies cellular mechanics as a critical regulator of senescence. Cells continuously sense and transduce extracellular mechanical signals, which reshape cytoskeletal architecture, nuclear mechanics, and chromatin organization. In this review, we summarize multi-scale mechanical alterations associated with senescence, including altered cellular traction force, cytoskeletal disorganization, and impaired nuclear mechanotransduction. We further discuss key mechanosensitive pathways that govern senescence initiation and progression. Finally, we highlight emerging mechanical approaches for identifying senescent cells and discuss the therapeutic potential of mechanics-based interventions, including mechanical stimulation, microenvironment remodeling, and targeted modulation of mechanotransduction, for aging and regenerative medicine.
Why this matters
Mechanotransduction has moved from a cell-biology curiosity to one of the proposed causal substrates of senescence, and this review consolidates that shift by cataloging stiffness, force, and cytoskeletal inputs as both drivers and potential therapeutic levers of the aging program. It frames a therapeutic narrative (mechanical stimulation, matrix remodeling, mechanotransduction-targeted drugs) that currently sits on preclinical and conceptual evidence — the biology-to-pitch gap this area tracks. Its practical weight is as framework-level synthesis, not as a new experimental result.